Form 4: Elanco Executive Acquires Deferred Stock Units

Sentiment:

Insider Transaction Report


Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired 66.4453 deferred stock units at a price of $21.29 per unit.

Summary

  • Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation and a Director at Elanco Animal Health Inc. (ELAN), acquired deferred stock units.
  • The transaction involved the acquisition of 66.4453 Deferred Stock Units (DSUs).
  • Each DSU represents the right to receive one share of Company common stock or its cash equivalent.
  • The DSUs were acquired at a price of $21.29 per unit.
  • Following this transaction, Modi beneficially owns a total of 7,357.4821 Deferred Stock Units.
  • The DSUs are scheduled to settle in cash or shares of common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.
  • The transaction date was December 12, 2025.

Sentiment

Score: 6

Explanation: Slightly positive as an executive is increasing their equity stake, which can be interpreted as a sign of confidence in the company's future, even if it's a routine compensation-related acquisition.

Positives

  • An executive acquiring additional equity (even deferred units) can signal confidence in the company's future prospects.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary acquisition.

Negatives

  • No specific negatives are apparent from this routine insider transaction filing.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This routine insider transaction filing does not provide sufficient information to analyze broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: May view the executive's increased equity stake as a positive signal of management's alignment with shareholder interests and confidence in the company's long-term value.

Next Steps

  • The Deferred Stock Units will settle in cash or shares of Company common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Key Dates

DateDescription
12/12/2025Date of earliest transaction for the acquisition of Deferred Stock Units.
12/16/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Keywords

Elanco Animal Health, ELAN, Rajeev A. Modi, Deferred Stock Units, DSU, Insider Transaction, SEC Form 4, Executive Compensation, Equity Acquisition, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.